ID
EN
Website ini sudah didukung oleh fitur aksesibilitas. Silahkan aktifkan fitur microsoft narator / android talkback / mac dan ios voiceover di perangkat anda.
Good Corporate Governance
In order to build good corporate governance, the Company shall have a commitment, consistent, and persistent from all relevant parties, i.e : all management levels, Employees, Board of Commissioners, Government and other Stakeholders.
- Good Corporate Governance
- Quality Assurance Control
- Responsibilty to Customer
- Corporate Governance Implementation Process
- Gratification Control Process
- Process of Whistle Blowing System
- Guidelines for The Board of Commisioner and Director
- Biofarma Code of Conduct
- Guidelines for Handling Conflict of Interest
- Charter
- Risk Management
- Directors Guidelines
- Audit Committee
- Development Risk and GCG Committee
- Superior Performance Assessment Criteria
Bio Farma secara konsisten dan berkesinambungan melakukan pengawasan dan jaminan mutu dengan menerapkan Good Manufacturing Practices (cGMP), Good Laboratory Practices (GLP), Good Regulatory Practices (GRP), Good Clinical Practices (GCP), Good Distribution Practices (GDP), ISO 9001, ISO 14001 dan OHSAS 18001. Prosedur pengawasan dan jaminan mutu ini dipantau secara ketat oleh National Control Authority (NCA) yang diakui oleh badan kesehatan dunia (WHO), atau di Indonesia dikenal dengan Badan Pengawasan Obat dan Makanan (BPOM).
Pra-Kualifikasi WHO (PQ-WHO)
Badan Kesehatan Dunia (WHO) menghimbau seluruh negara anggota agar hanya menggunakan vaksin yang memenuhi persyaratan WHO dalam program imunisasinya. Bio Farma sejak tahun 1997 telah mengikuti prosedur sistem terintegrasi dan Quality Management System sehingga mendapatkan pengakuan Pra-Kualifikasi (PQ) WHO.
The following are Bio Farma's product milestones that have obtained WHO PQ:
